Report cover image

Precision Medicine Market Size, Share, and Analysis, By Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), By Application (Oncology, Rare diseases, Hematology, Infectious, and Others), By Technology (Genomics, Trans

Publisher Fatpos Global
Published Dec 01, 2023
Length 376 Pages
SKU # FAGL18583720

Description

Precision Medicine Market Size, Share, and Analysis, By Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), By Application (Oncology, Rare diseases, Hematology, Infectious, and Others), By Technology (Genomics, Transcriptomics and Epigenomics, and Others), By End User (Hospitals & Clinics, Home care), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032


PRODUCT OVERVIEW

Precision Medicine Market is expected to grow at a CAGR of 12.1% in the forecast period (2023-2032), with the market size valued at USD 39.66 billion in 2021 and projected to reach USD 138.6 billion by 2032.

Precision medicine, sometimes referred to as personalized medicine, is a healthcare strategy that customizes medical judgments, therapies, and treatments to specific patients by considering their distinctive genetic make-up, way of life, and environmental circumstances. It has become more well-known as a result of developments in genomics, genomic sequencing technology, and data analysis, which make it possible to identify genetic variations linked to diseases and provide tailored treatments. Precision medicine includes diagnostic tools, biomarker testing, and the integration of complicated patient data utilizing artificial intelligence and machine learning. It is mostly prominent in oncology but is moving into other medical fields. It is a dynamic and evolving industry since regulatory bodies are actively involved in forming the regulatory framework, yet issues with data privacy, standardization, and reimbursement still exist.

MARKET HIGHLIGHTS

Precision Medicine Market is expected to reach USD 138.6 billion, growing at a CAGR of 12.1%. Advances in genomics and genetic sequencing technology are principally responsible for the sector of precision medicine's present remarkable expansion. These developments make it easier to find the genetic differences linked to diseases and to provide personalized treatments after that. Precision medicine is finding uses outside of oncology, increasing demand for diagnostic equipment and biomarker testing. The precision of treatment decisions is also being improved by the incorporation of substantial patient data and the use of artificial intelligence for data analysis. Precision medicine is positioned as a dynamic and promising strategy for improving patient care and outcomes thanks to regulatory authorities' support and the continual evolution of guidelines.

Precision Medicine Market Segments:
  • By Type
  • Inhibitors
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Antivirals
  • Antiretroviral
  • By Technology
  • Genomics
  • Transcriptomics and Epigenomics
  • Others
  • By Application
  • Oncology
  • Rare diseases
  • Haematology
  • Infectious
  • Others
  • By End Users
  • Hospitals & Clinics
  • Home care
MARKET DYNAMICS

Growth Drivers

Expansion of Genetic Testing and Related Procedures to Boost the Market

Increasing Demand for Cell and Gene Therapies will Hasten Market Expansion

Restraint

High Cost of Therapy is Hurting the Market

Key Players
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Roche Holding AG
  • Qiagen N.V.
  • Myriad Genetics, Inc.
  • Exact Sciences Corporation
  • Bristol-Myers Squibb
  • Novartis AG
  • Amgen Inc.
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Bio-Rad Laboratories, Inc.
  • Foundation Medicine, Inc.
  • Becton, Dickinson and Company (BD)
  • Tempus, Inc.
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*

Table of Contents

376 Pages
1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Precision Medicine Market: COVID-19. Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Precision Medicine Market: COVID-19. Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Precision Medicine Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19. overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Precision Medicine Market
10.1. Overview
10.2. Historical Analysis (2019-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Precision Medicine Market Size & Forecast 202. A-203. F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.1.1. Inhibitors
11.3.1.1.1. By Value (USD Million) 2022-203. F
11.3.1.1.2. Market Share (%) 2022-203. F
11.3.1.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.1.2. Monoclonal Antibodies
11.3.1.2.1. By Value (USD Million) 2022-203. F
11.3.1.2.2. Market Share (%) 2022-203. F
11.3.1.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.1.3. Cell & Gene Therapy
11.3.1.3.1. By Value (USD Million) 2022-203. F
11.3.1.3.2. Market Share (%) 2022-203. F
11.3.1.3.3. Y-o-Y Growth (%) 2022-203. F
11.3.1.4. Antivirals
11.3.1.4.1. By Value (USD Million) 2022-203. F
11.3.1.4.2. Market Share (%) 2022-203. F
11.3.1.4.3. Y-o-Y Growth (%) 2022-203. F
11.3.1.5. Antiretroviral
11.3.1.5.1. By Value (USD Million) 2022-203. F
11.3.1.5.2. Market Share (%) 2022-203. F
11.3.1.5.3. Y-o-Y Growth (%) 2022-203. F
11.3.2. By Application
11.3.2.1. Oncology
11.3.2.1.1. By Value (USD Million) 2022-203. F
11.3.2.1.2. Market Share (%) 2022-203. F
11.3.2.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.2.2. Rare Disease
11.3.2.2.1. By Value (USD Million) 2022-203. F
11.3.2.2.2. Market Share (%) 2022-203. F
11.3.2.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.2.3. Hematology
11.3.2.3.1. By Value (USD Million) 2022-203. F
11.3.2.3.2. Market Share (%) 2022-203. F
11.3.2.3.3. Y-o-Y Growth (%) 2022-203. F
11.3.2.4. Infectious
11.3.2.4.1. By Value (USD Million) 2022-203. F
11.3.2.4.2. Market Share (%) 2022-203. F
11.3.2.4.3. Y-o-Y Growth (%) 2022-203. F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2022-203. F
11.3.2.5.2. Market Share (%) 2022-203. F
11.3.2.5.3. Y-o-Y Growth (%) 2022-203. F
11.3.3. By Technology
11.3.3.1. enomics
11.3.3.1.1. By Value (USD Million) 2022-203. F
11.3.3.1.2. arket Share (%) 2022-203. F
11.3.3.1.3Y-o-Y Growth (%) 2022-203. F
11.3.3.2. ranscriptomics and Epigenomics
11.3.3.2.1. y Value (USD Million) 2022-203. F
11.3.3.2.2. Market Share (%) 2022-203. F
11.3.3.3.1Y-o-Y Growth (%) 2022-203. F
11.3.3.3. thers
11.3.3.3.1. y Value (USD Million) 2022-203. F
11.3.4.1.2. arket Share (%) 2022-203. F
11.3.4.1.3Y-o-Y Growth (%) 2022-203. F
11.3.4. y End Users
11.3.4.1. Hospitals and Clinics
11.3.4.1.1. By Value (USD Million) 2022-203. F
11.3.4.1.2. arket Share (%) 2022-203. F
11.3.4.1.3Y-o-Y Growth (%) 2022-203. F
11.3.4.2. omecare
11.3.4.2.1. y Value (USD Million) 2022-203. F
11.3.4.2.2. Market Share (%) 2022-203. F
11.3.4.2.3. Y-o-Y Growth (%) 2022-203. F
12. North America Precision Medicine Market Size & Forecast 202. A-203. F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Technology
12.3.2. By End Users
12.3.3. By Type
12.3.4. By Application
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Precision Medicine Market Size & Forecast 202. A-203. F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Technology
13.3.2. By End Users
13.3.3. By Type
13.3.4. By Application
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Precision Medicine Market Size & Forecast 202. A-203. F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Technology
14.3.2. By End Users
14.3.3. By Type
14.3.4. By Application
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Precision Medicine Market Size & Forecast 202. A-203. F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Technology
15.3.2. By End Users
15.3.3. By Type
15.3.4. By Application
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Precision Medicine Market Size & Forecast 202. A-203. F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Technology
16.3.2. By End Users
16.3.3. By Type
16.3.4. By Application
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Illumina, Inc.
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3. Yrs.)
18.1.4.5. Executive Team
18.2. Thermo Fisher Scientific, Inc.
18.3. Roche Holding AG
18.4. Qiagen N.V.
18.5. Myriad Genetics, Inc.
18.6. Exact Sciences Corporation
18.7. Bristol-Myers Squibb
18.8. Novartis AG
18.9. Amgen Inc.
18.10. AstraZeneca PLC
18.11. Gilead Sciences, Inc.
18.12. Bio-Rad Laboratories, Inc.
18.13. Foundation Medicine, Inc.
18.14. Becton, Dickinson and Company (BD)
18.15. Tempus, Inc.
18.16. Other Prominent Players
19. Appendix
20. Consultant Recommendation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us